CVS, Walgreens pull back COVID vaccines in more than a dozen states following new guidelines

30.08.25 15:39 Uhr

Werte in diesem Artikel
Aktien

60,95 EUR 0,96 EUR 1,60%

Indizes

PKT PKT

17.718,6 PKT 68,8 PKT 0,39%

3.234,7 PKT 14,8 PKT 0,46%

6.512,6 PKT 17,5 PKT 0,27%

CVS and Walgreens are reportedly scaling back access to updated COVID-19 vaccines in several states following new federal guidelines that limit eligibility to only seniors and high-risk groups. Based on the "current regulatory environment," CVS has completely stopped offering the shots in three states – Massachusetts, Nevada and New Mexico – and has limited access in 13 others as well as the District of Columbia, according to CVS Health spokesperson Tara Burke.States with restricted access include Arizona, Colorado, Florida, Georgia, Kentucky, Louisiana, Maine, New York, North Carolina, Pennsylvania, Utah, Virginia, West Virginia and the District of Columbia, Burke said."We’ll administer FDA-authorized COVID-19 vaccines in states where legally permitted at CVS Pharmacy and/or MinuteClinic to meet our patients’ needs," Burke said.FDA LIMITS NEW COVID VACCINE BOOSTERS TO HIGH-RISK AMERICANS ONLYWalgreens is "prepared to offer the vaccine in states where we are able to do so," according to CBS News, citing a company statement.In regions where distribution is limited, high-risk individuals may still receive the updated boosters if they obtain a prescription from an authorized provider.CVS CAREMARK ORDERED TO PAY $290M AFTER MEDICARE FRAUD SCHEME EXPOSED BY FORMER AETNA WHISTLEBLOWEREarlier this week, the U.S. Food and Drug Administration (FDA) ended emergency use authorization for COVID-19 vaccines and approved updated shots only for seniors and people with underlying conditions that put them at higher risk of severe illness. Moderna's vaccine was approved for market authorization for people 6 months and older, Pfizer’s for those 5 years old and older, and Novavax’s for individuals at least 12 years old.CVS OPENS SMALLER FORMAT STORES AS INDUSTRY SEES BIG SHIFTHealth and Human Services Secretary Robert F. Kennedy Jr. announced the FDA’s most recent actions on Wednesday in a post on X."I promised 4 things," Kennedy said. "1. to end covid vaccine mandates; 2. to keep vaccines available to people who want them, especially the vulnerable; 3. to demand placebo-controlled trials from companies; 4. to end the emergency.""In a series of FDA actions today we accomplished all four goals," he added.GET FOX BUSINESS ON THE GO BY CLICKING HERE"The American people demanded science, safety, and common sense. This framework delivers all three," Kennedy said.Walgreens did not immediately respond to a request for comment from FOX Business.Weiter zum vollständigen Artikel bei FOX Business

In eigener Sache

Übrigens: CVS Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CVS Health

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CVS Health

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: FOX Business

Nachrichten zu CVS Health Corp

Wer­bung

Analysen zu CVS Health Corp

DatumRatingAnalyst
05.06.2019CVS Health BuyStandpoint Research
15.04.2019CVS Health PerformOppenheimer & Co. Inc.
12.04.2019CVS Health Market PerformBMO Capital Markets
18.12.2018CVS Health OverweightBarclays Capital
26.10.2018CVS Health Peer PerformWolfe Research
DatumRatingAnalyst
05.06.2019CVS Health BuyStandpoint Research
12.04.2019CVS Health Market PerformBMO Capital Markets
18.12.2018CVS Health OverweightBarclays Capital
30.01.2018CVS Health Strong BuyNeedham & Company, LLC
02.01.2018CVS Health BuyNeedham & Company, LLC
DatumRatingAnalyst
15.04.2019CVS Health PerformOppenheimer & Co. Inc.
26.10.2018CVS Health Peer PerformWolfe Research
28.06.2017CVS Health HoldNeedham & Company, LLC
02.02.2017CVS Health NeutralRobert W. Baird & Co. Incorporated
22.06.2016CVS Health HoldDeutsche Bank AG
DatumRatingAnalyst
25.07.2005Update Longs Drug Stores Corp.: UnderperformBear Stearns

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CVS Health Corp nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen